Private company
Aisling Capital IV, LP
American company, incorporated in Delaware. Summary from the record
Last updated Oct 21, 2026.
Overview
- HeadquartersDE1
Corporate structure
Aisling Capital IV, LP sits at the top of its group. 4 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
- Aisling Capital IV, LP DE
- Elevation Oncology, Inc. Stake · Boston, Massachusetts
- Marker Therapeutics, Inc. Stake · Houston, Texas
- Viracta Therapeutics, Inc. Stake · South San Francisco, California, United States
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (3 companies). Each entity in the chart links to its source.
Stakes it holds
Aisling Capital IV, LP has told the SEC it owns more than 5% of 3 companies, latest first (Schedules 13D and 13G).
- Elevation Oncology, Inc.SC 13G/A Feb 14, 2022 to Nov 12, 20242
- Marker Therapeutics, Inc.SC 13D/A Mar 3, 20233
- Viracta Therapeutics, Inc.SC 13G Feb 14, 20224
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4